Use of a peptide and an analgesic pharmaceutical agent
US9486493B2 · kind B2 · utility
0Cited by
1References
19Claims
0Family size
Inventors
Key dates
| Filing date | Mar 7, 2008 |
| Grant date | Nov 8, 2016 |
| Priority date | — |
| Expiry date | Sep 6, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Inflammation caused by disease states such as rheumatism, gout, neurodegeneration and tumours result in the increased effectiveness of the opioid peptide biphalin or its analogues, due likely to the increased permeability of the “blood-brain barrier”, due to which it becomes possible to use the opioid peptide to produce a new analgesic for use during inflammation caused by rheumatism, gout, neurodegeneration, post-surgical or post-accidental trauma or tumours.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.